Kevin Czerney - 04 Mar 2026 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role: VP, Chief Accounting Officer
Signature: /s/ Jessica Nielsen Causey, Attorney-In-Fact for Kevin Czerney
Issuer symbol: XRAY
Transactions as of: 04 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 06 Mar 2026, 17:28:20 UTC
Previous filing: 05 Mar 2026
Next filing: 12 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Czerney Kevin	VP, Chief Accounting Officer	C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Kevin Czerney	06 Mar 2026	0002044443

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XRAY	Common Stock	Award		+13,690	+50%	$0.000000^*	41,269	04 Mar 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XRAY	Stock Option (Right to Buy)	Award		+10,400		$0.000000^*	10,400	04 Mar 2026	Common Stock	10,400	$14.78	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029.
F2	Stock options vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant.